15. MONOSTOTIC AND POLYOSTOTIC FIBROUS DYSPLASIA, AND MCCUNE-ALBRIGHT SYNDROME: CASE REPORTS AND LITERATURE REVIEW
Main Article Content
Abstract
Objective: This article presents the clinical features, imaging findings, treatment methods, and outcomes of five cases of fibrous dysplasia, along with a literature review to emphasize the importance of accurate diagnosis and appropriate management.
Methods: A case series of five patients diagnosed with fibrous dysplasia at Hospital for Traumatology and Orthopaedics at Ho Chi Minh city is described. Data collected include clinical presentation, imaging, treatment, and postoperative follow-up. A literature review was also conducted using updated sources.
Results: Among the 5 cases, 3 patients had monostotic fibrous dysplasia, 1 had polyostotic fibrous dysplasia, and 1 was diagnosed with McCune-Albright syndrome. 4 patients underwent surgery due to pathological fractures, and 1 patient was treated for bone deformity and persistent pain. Surgical treatments included locking plate fixation and intramedullary nailing. Overall, treatment outcomes were favorable with no major complications.
Conclusion: Fibrous dysplasia presents with diverse manifestations and requires individualized treatment. Surgery is indicated in symptomatic cases, and long-term follow-up plays a crucial role.
Article Details
Keywords
Fibrous dysplasia, pathological fracture, surgical treatment, McCune-Albright syndrome.
References
[2] DiCaprio M.R, Enneking W.F. Fibrous dysplasia. Pathophysiology, evaluation, and treatment. J Bone Joint Surg Am, 2005, 87 (8): 1848-64.
[3] Board WCoTE. McCune-Albright syndrome. In: Board WCoTE, editor. WHO Classification of Tumours: Soft Tissue and Bone Tumours. 5th ed. Lyon: International Agency for Research on Cancer, 2020, p. 514-6.
[4] Javaid M.K, Boyce A, Appelman-Dijkstra N, Ong J, Defabianis P, Offiah A et al. Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium. Orphanet journal of rare diseases, 2019, 14: 1-17.
[5] Baghdadi S, Arkader A. Fibrous dysplasia: recent developments and modern management alternatives. Journal of the Pediatric Orthopaedic Society of North America, 2020, 2 (2): 84.
[6] Arkell C, van Heerden J. Fibrous dysplasia: a current concepts review. SA Orthopaedic Journal, 2023, 22 (4): 208-17.
[7] Boyce A.M, Kelly M.H, Brillante B.A, Kushner H, Wientroub S, Riminucci M et al. A randomized, double blind, placebo-controlled trial of alendronate treatment for fibrous dysplasia of bone. The Journal of Clinical Endocrinology & Metabolism, 2014, 99 (11): 4133-40.
[8] Chapurlat R.D, Gensburger D, Jimenez-Andrade J.M, Ghilardi J.R, Kelly M, Mantyh P. Pathophysiology and medical treatment of pain in fibrous dysplasia of bone. Orphanet journal of rare diseases, 2012, 7 (Suppl 1): S3.
[9] Leet A.I, Boyce A.M, Ibrahim K.A, Wientroub S, Kushner H, Collins M.T. Bone-grafting in polyostotic fibrous dysplasia. JBJS, 2016, 98 (3): 211-9.
[10] Ebeid W.A, Hasan B.Z, Mesregah M.K. Management of Fibrous Dysplasia of Proximal Femur by Internal Fixation Without Grafting: A Retrospective Study of 19 Patients. J Am Acad Orthop Surg Glob Res Rev, 2018, 2 (10): e057.
[11] Majoor B.C, Leithner A, van de Sande M.A, Appelman-Dijkstra N.M, Hamdy N.A, Dijkstra P.S. Individualized approach to the surgical management of fibrous dysplasia of the proximal femur. Orphanet journal of rare diseases, 2018, 13: 1-13.